Processing

Please wait...

Settings

Settings

Goto Application

1. WO2018126127 - COMPOSITION OF MATTER AND USE THEREOF FOR PREVENTING AND TREATING MOTION SICKNESS

Publication Number WO/2018/126127
Publication Date 05.07.2018
International Application No. PCT/US2017/068944
International Filing Date 29.12.2017
IPC
A61K 9/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
06Ointments; Bases therefor
A61K 9/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
10Dispersions; Emulsions
A61K 9/70 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
70Web, sheet or filament bases
A61K 31/24 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
235having an aromatic ring attached to a carboxyl group
24having an amino or nitro group
A61K 31/133 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
13Amines, e.g. amantadine
133having hydroxy groups, e.g. sphingosine
A61K 31/135 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
13Amines, e.g. amantadine
135having aromatic rings, e.g. methadone
CPC
A61K 31/216
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
216of acids having aromatic rings, e.g. benactizyne, clofibrate
A61K 9/0014
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
0014Skin, i.e. galenical aspects of topical compositions
A61K 9/7023
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
70Web, sheet or filament bases ; ; Films; Fibres of the matrix type containing drug;
7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
A61P 1/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
08for nausea, cinetosis or vertigo; Antiemetics
Applicants
  • GT BIOPHARMA, INC. [US]/[US]
Inventors
  • CLARENCE-SMITH, Kathleen E.
Agents
  • PHAN, Tu A.
  • TOWNSLEY, Alan C.
  • BIRD, John M.
Priority Data
62/440,57530.12.2016US
62/595,66707.12.2017US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) COMPOSITION OF MATTER AND USE THEREOF FOR PREVENTING AND TREATING MOTION SICKNESS
(FR) COMPOSITION DE MATIÈRE ET SON UTILISATION POUR LA PRÉVENTION ET LE TRAITEMENT DU MAL DES TRANSPORTS
Abstract
(EN)
Motion sickness in a mammalian subject, in particular, a human, may be prevented or treated by administering to a mammalian, a transdermal device system releasing oxybutynin or one of its enantiomers, such as (R)-oxybutynin.
(FR)
Selon l'invention, le mal des transports chez un sujet mammifère, en particulier un être humain, peut être empêché ou traité par l'administration au mammifère d'un système à dispositif transdermique qui libère de l'oxybutynine ou un de ses énantiomères, tel que le (R)-oxybutynine.
Also published as
Latest bibliographic data on file with the International Bureau